Harrow Health IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 38.94 USD | 54,85 USD | 28,54 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 67,75 USD | 4 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 37.275.107 | 20,44 | 9,32 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Harrow Health Inc
Mitarbeiter 373
Handelsplatz NASDAQ
Ticker Symbol HROW
IPO Datum 2007-09-28
Adresse 1A Burton Hills Boulevard, Nashville, TN, United States, 37215
Webseite https://www.harrow.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mark L. Baum J.D. | CEO, Chairman of the Board & Founder |
| 2 | Mr. Andrew R. Boll C.F.A., C.M.A. | President, CFO & Corporate Secretary |
| 3 | Dr. Amir W. Shojaei Ph.D., Pharm.D. | Chief Scientific Officer |
| 4 | Mr. Francis W. Mullery | President & CEO of Harrow's ImprimisRx Division |
| 5 | Mr. Randall E. Pollard | Chief Accounting Officer |
| 6 | Mr. Michael D. Biega | Vice President of Investor Relations & Communications |
| 7 | Mr. Brett A. Burrell | Vice President of Legal & Compliance |
| 8 | Ms. Kim Barratt | Chief Talent Officer |
| 9 | Dr. Mark A. Mannebach Ph.D., R.Ph. | Head of Regulatory Affairs & Pharmacovigilance |
| 10 | Dr. Prashanth S. Annavajjhala | Chief of Staff |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Opaleye Management Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Private Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Luxor Capital Group, LP | 0,00% | 0,00 Mio. USD |
| 7 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 8 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Marshall Wace Asset Management Ltd | 0,00% | 0,00 Mio. USD |
| 10 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 11 | Ikarian Capital, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 13 | Penn Capital Management Company LLC | 0,00% | 0,00 Mio. USD |
| 14 | Rice Hall James & Associates, LLC | 0,00% | 0,00 Mio. USD |
| 15 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 16 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 17 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 19 | New York State Common Retirement Fund | 0,00% | 0,00 Mio. USD |
| 20 | Stifel Financial Corp | 0,00% | 0,00 Mio. USD |